Clinical Trial Update: Clinical Study on the Treatment of Systemic Sclerosis With UTAA91 Injection. [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial is evaluating UTAA91 injection for Systemic sclerosis conducted by PersonGen BioTherapeutics (Suzhou) Co., Ltd.; the study is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• UTAA91 injection

Snippet

Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Conditions: Systemic Sclerosis (SSc) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING